Several Drugs within this class that have been removed from clinical practice. Their use being severely restricted, banned by Foreign Governments, currently under FDA scrutiny or withdrawn by their manufacturers due to severe toxicity issues. Numerous fatal adverse reactions as well as permanent injury to the patient have been reported.
Moxifloxaciin (Avelox®)Do Not Use
The European Medicines Agency has recommended limiting the use
of moxifloxacin after finalizing the review of the safety of Avelox. These
drugs should only be prescribed for acute bacterial sinusitis,
acute exacerbation of chronic bronchitis and community-acquired
pneumonia when other antibiotics cannot be used or have failed.
Norfloxacin(Noroxin®)
Do Not Use
The European Medicines
Agency has recommended restricting the use
of oral norfloxacin urinary infections. CHMP has concluded that the
marketing authorizations for norfloxacin, when used in the treatment of
acute or chronic complicated pyelonephritis, should be withdrawn
because the benefits do not outweigh their risks in this indication.
Gemifloxacin (Factive®)Do Not Use
Six YEARS later the FDA now believes that Gemifloxacin (Factive)
should be studied further due to reports of disfiguring skin reactions
Cinoxacin (Cinobac®)Do Not Use
First approved in 1980, it has been reported to have been discontinued
and no longer available.
Gatifloxacin (Tequin®)Do Not Use
Since the approval of gatifloxacin in 1999, there have been cases of life
threatening events reported globally in patients treated with the drug.
Enoxacin (Penetrex®)Do Not Use
Reported to have been removed from clinical use by
the manufacturer
Grepafloxacin (Raxar®)Do Not Use
Removed from clinical use due to severe toxicity
(ie: qt time)
Sparfloxacin (Zagam ®)Do Not Use
Removed from clinical use due to sever toxicity
(ie: qt time, phototoxic reactions)
Temafloxacin (Omniflox®)
Do Not Use
Removed from clinical use due to severe toxicity
(ie: hemolytic hepatic reactions)
Trovafloxacin
(Trovan ®)Do Not Use
Removed from clinical use due to severe toxicity
(ie: hepatic reactions)
A Public Service Announcement
Levaquin Tendon
Problems - Are They Really a
Rare Occurrence? Ithas been reported that the Law Firm of Lewis Saul & Associates is
investigating multiple cases of tendon injury associated with the
antibiotic, Levaquin. If you have had a tendon injury related to the
use of Levaquin the Fluoroquinolone Toxicity Research Foundation
suggest you contact Lewis Saul & Associates at:
http://lewissaul.com
The above message provided strictly as a public service. There is no association between the foundation and this law firm. For additional legal referrals please click on the LEGAL link located at the left side of this page.
Gary
and Ruth Pettijohn, of Batesville, Ind., hold a photo of their daughter, Kristen, who died after being prescribed a powerful antibiotic
called Avelox. Early in the morning of May 15, Pettijohn's mother took
her to an emergency room. Forty-two minutes later, Pettijohn was on
her way to the drugstore. The doctor had diagnosed her with acute
bronchitis and prescribed Avelox. That was a Thursday. By Sunday,
Kristen was nauseated and suffering abdominal pain. Her mother packed
a plastic bag with the remaining Avelox pills and took her to the hospital.
Over the next five days, Kristen was incoherent. She had a burning rash
and her skin began peeling off. She slipped into a coma, resting on an air bed, totally wrapped
as though she were a severe burn patient. Kristen's liver was in full failure, and she was
experiencing a form of Stevens-Johnson syndrome, a rare and extreme drug reaction
mentioned on the Avelox label. She had a liver transplant on Friday. The doctors reported
that her old liver had turned to mush and fallen apart in their hands. Soon after the operation,
Kristen had a heart attack, then another. Her death certificate cited Avelox as the prime
contributing factor in her death.
Click here to Continue
Last
May Paul Levine took a Fluoroquinolone antibiotic (Levaquin) thathe had a severe reaction to. His symptoms got progressively worse and
he became very sensitive to many foods and other environmental factors.
The pains increased and he wasn't able to sleep. His mental, emotional
and physical condition worsened and in the last few months he was calling
on his close friends to stay on the phone with him through his toughest
times, sometimes for hours during the middle of the night. He couldn't
bear the pain any longer and felt that there was no one on Earth that could
help him. At midday on Wednesday, March 3, 2004, he took his own life.
Click here to Continue
On May 23, 2002, Kim Crawley was prescribed Cipro by her Primary Care Physician for what was thought to be bronchitis or possibly
pneumonia. No sputum test were done, no chest x-ray. Kim had both
kidney and liver problems due to damage for cancer years ago. On the
morning of May 25th, Kim complained of extreme tiredness, laid down to
rest, and in a matter of seconds stopped breathing. Paramedics were
unable to revive her and she was pronounced dead. Her parents had talked
to several nurses who are familiar with Cipro and the Methylprednisolone
and all agreed she should have NEVER been prescribed either of those
meds with her history of kidney and liver problems.
Click Here to Continue
OTHER ASSOCIATED FATALITIESAdditional Published fatalities that have been reported regarding the
ingestion of Fluoroquinolones.
Click here to Continue